Therefore, we analyzed the relationship between the above-mentioned immune checkpoints and the clinical prognosis of BC patients by searching the GEPIA2 database, and found that PDCD1, CTLA4, TIGIT, and BTLA were closely linked to the prognosis of BC patients. The gene discussed is TIGIT; the disease is breast cancer.